Review expert recommendations and key evidence for the use of immune checkpoint inhibitors in MSI-H gastrointestinal cancers in an expert panel discussion led by John L. Marshall, MD, along with Tim F. Greten, MD, and Yelena Y. Janjigian, MD. This program is divided into 4 segments. After clicking the Launch buttons below, the player will open in a new window. If it does not appear, please disable your pop-up blocker and try again. After reviewing all segments, click the Claim Credit button to the right to complete the CME posttest and evaluation.
In this downloadable slideset, John L. Marshall, MD, Yelena Janjigian, MD, and Tim F. Greten, MD provide expert guidance on incorporating the latest data and newest therapies into the management of MMR-deficient/MSI-high gastrointestinal cancers.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.